I now have comprehensive content from multiple authoritative textbooks and four excellent diagrams. Let me compile the full answer.
Iron Biochemistry
1. Total Body Iron Content and Distribution
The total iron in the body averages 4-5 grams in adults, distributed as follows:
| Compartment | % of Total | Amount |
|---|
| Hemoglobin (erythrocytes) | ~65% | ~2,500 mg |
| Myoglobin (muscle) | ~4% | ~150 mg |
| Heme enzymes (cytochromes, catalase, peroxidase) | ~1% | ~15 mg |
| Transferrin (plasma transport) | ~0.1% | ~3 mg |
| Storage (ferritin + hemosiderin) | 15-30% | 200-1,000 mg liver + ~600 mg macrophages |
- Guyton and Hall Textbook of Medical Physiology, p. 446
- Harrison's Principles of Internal Medicine 22E, p. 806
2. Iron's Functional Roles
Iron is indispensable for:
- Oxygen transport - as the core of heme in hemoglobin and myoglobin
- Cellular respiration - cytochromes and cytochrome oxidase in the electron transport chain
- Antioxidant defense - catalase and peroxidase
- DNA synthesis - ribonucleotide reductase (non-heme iron)
- Energy production - iron-sulfur (Fe-S) clusters in mitochondrial complexes
- Cell cycle regulation - iron utilized in mitochondria to form heme and Fe-S clusters
Because free iron generates reactive oxygen species (ROS) via Fenton chemistry, it is always protein-bound and its homeostasis is tightly regulated.
3. Intestinal Absorption
Only 1-2 mg/day is absorbed from the diet (dietary intake is ~15 mg/day; ~6 mg per 1,000 kcal).
Heme iron
- Derived from red meat myoglobin and hemoglobin
- Taken up intact by enterocytes via an undefined mechanism
- Constitutes only ~6% of dietary iron but represents ~30% of absorbed iron
- Not affected by dietary inhibitors
Non-heme iron
- Must be reduced from Fe³+ → Fe²+ before absorption
- Steps:
- Gastric acid lowers luminal pH, facilitating reduction
- Duodenal cytochrome B (DCYTB) - a brush-border ferrireductase converts Fe³+ to Fe²+
- DMT1 (Divalent Metal Transporter 1) imports Fe²+ across the apical membrane into the enterocyte
- Iron is either stored as ferritin within the enterocyte or exported at the basolateral membrane by ferroportin
- At the basolateral surface, hephaestin (a ceruloplasmin-like oxidase) re-oxidizes Fe²+ to Fe³+, which then binds transferrin in plasma
Enhancers of absorption: ascorbic acid, meat, acidic pH
Inhibitors: phytates, phosphates (in vegetables/cereals), tannins (tea, coffee)
- Goodman & Gilman's The Pharmacological Basis of Therapeutics, p. 927
- Harrison's Principles of Internal Medicine 22E, p. 806
4. Plasma Transport: Transferrin
- Transferrin is a 76 kDa beta-globulin glycoprotein synthesized by the liver
- Each molecule has two binding sites for Fe³+ (monoferric or diferric)
- Normal plasma level: 204-360 mg/dL
- Carries only ~3-4 mg of iron but turns over 10x per day (~30-40 mg/day flux)
- ~80% of plasma iron is delivered to the erythroid marrow for hemoglobin synthesis
Transferrin Receptor-Mediated Uptake (TfR1)
- Diferric transferrin binds TfR1 (CD71) on the cell surface
- The complex is internalized via clathrin-coated pit endocytosis
- A proton-pumping ATPase acidifies the endosome to ~pH 5.5
- Iron dissociates from transferrin; STEAP3 (a ferrireductase) reduces Fe³+ to Fe²+
- DMT1 transports Fe²+ into the cytosol, then to mitochondria for heme synthesis
- Apotransferrin returns to the cell surface and is released back into circulation
- Henry's Clinical Diagnosis and Management by Laboratory Methods, p. 675
- Goodman & Gilman's The Pharmacological Basis of Therapeutics, p. 927
5. Iron Storage: Ferritin and Hemosiderin
Ferritin
- A protein-iron storage complex; apoferritin MW ~450-460 kDa
- Composed of 24 subunits (H-heavy and L-light chains)
- H subunits have ferroxidase activity (oxidize Fe²+ to Fe³+ for incorporation)
- H gene on chromosome 11; L gene on chromosome 19
- Central cavity stores a crystalline core of ferric oxyhydroxide (FeOOH)
- Can hold up to 4,000 atoms of iron per molecule; >30% of its weight may be iron
- Water-soluble, iron is readily mobilizable
Hemosiderin
- Aggregates of FeOOH core crystals with partially degraded protein shells (lysosomal proteolysis)
- Water-insoluble; visible as large granules under light microscopy
- Iron is much harder to mobilize than ferritin iron
- Accumulates when total body iron exceeds apoferritin storage capacity
Storage sites: reticuloendothelial system (liver Kupffer cells, splenic macrophages, bone marrow) and hepatocytes.
6. Iron Recycling by Macrophages
-
Senescent RBCs (lifespan ~120 days) are phagocytosed by splenic and liver macrophages
-
Hemoglobin → heme → iron is liberated within the macrophage
-
Heme is catabolized by heme oxygenase → biliverdin → bilirubin + Fe²+
-
Ferroportin on the macrophage surface exports iron back to plasma
-
This recycling provides ~20-25 mg iron/day - far exceeding the 1-2 mg dietary absorption
-
In intravascular hemolysis: hemoglobin-haptoglobin and heme-hemopexin complexes are taken up by hepatocytes and macrophages respectively
-
Harrison's Principles of Internal Medicine 22E, p. 807
7. The Iron Cycle (Visual)
Iron cycle: Transferrin is central to iron trafficking. Most iron (20-25 mg/day) is recycled from macrophages; only 1-2 mg comes from intestinal absorption. Hepcidin controls ferroportin activity.
- Harrison's Principles of Internal Medicine 22E
Quantitative iron flow: plasma iron pool of ~3 mg turns over ~10×/day; erythroid marrow uptake ~25 mg/day; RBC pool ~2,100 mg
- Goodman & Gilman's The Pharmacological Basis of Therapeutics
8. Hepcidin - The Master Regulator
Hepcidin is a 25-amino acid antimicrobial peptide encoded by the HAMP gene, produced and secreted by the liver. It is the primary systemic regulator of iron homeostasis.
Mechanism of Action
- Hepcidin binds to ferroportin on the surface of enterocytes, macrophages, and hepatocytes
- This triggers internalization and lysosomal degradation of ferroportin
- Reduced ferroportin activity means: less iron absorption from gut + less iron release from macrophage stores → hypoferremia
Hepcidin binds ferroportin on both enterocytes and macrophages, triggering its internalization and degradation
- Harper's Illustrated Biochemistry, 32nd Ed, p. 654
Signals that INCREASE hepcidin (reduce iron absorption)
| Signal | Pathway |
|---|
| High iron / high transferrin saturation | HFE-TfR2 complex → BMP-SMAD signaling |
| Inflammation | IL-6 → JAK-STAT pathway |
| BMP ligands + hemojuvelin (HJV) coreceptor | BMP receptor → SMAD → HAMP transcription |
Signals that DECREASE hepcidin (increase iron absorption)
| Signal | Mechanism |
|---|
| Iron deficiency | TMPRSS6 antagonizes BMP pathway |
| Hypoxia / hemorrhage | Erythroferrone (from erythroblasts) sequesters BMPs |
| Erythropoietin stimulation | Increases erythroferrone |
| Testosterone | Adapts supply to male erythropoiesis |
| FGL1 (fibrinogen-like protein 1) | Released by hepatocytes |
- Harrison's Principles of Internal Medicine 22E, p. 806
- Harper's Illustrated Biochemistry, 32nd Ed, pp. 653-654
- Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 788
9. Cellular Iron Regulation: IRP/IRE System
At the cellular level, iron supply is sensed by two Iron Regulatory Proteins (IRP1 and IRP2) - cytosolic RNA-binding proteins:
| mRNA target | IRE location | Effect of IRP binding (low iron) |
|---|
| Ferritin mRNA | 5' UTR | Represses translation (less storage) |
| TfR1 mRNA | 3' UTR | Stabilizes mRNA → more receptor expression (more uptake) |
| Ferroportin mRNA | 5' UTR | Represses translation (less export) |
| HIF-2α mRNA | 5' UTR | Regulates erythropoietin expression |
| ALAS2 mRNA (5'-aminolevulinate synthase) | 5' UTR | Regulates first step of heme synthesis |
Low iron → IRPs bind IREs:
- ↓ Ferritin (less storage)
- ↑ TfR1 (more uptake)
- Net effect: more iron captured
High iron → IRPs do not bind IREs:
-
↑ Ferritin (more storage)
-
↓ TfR1 (less uptake)
-
Net effect: excess iron stored safely
-
Goodman & Gilman's The Pharmacological Basis of Therapeutics, p. 927
-
Harrison's Principles of Internal Medicine 22E, p. 806
10. Iron Loss
The body has no regulated excretion mechanism for iron. Iron is lost passively:
- Men: ~0.6-1 mg/day (fecal, desquamated epithelial cells, sweat)
- Women: ~1.3 mg/day average (+ menstrual losses of ~0.5-1 mg/day)
- Pregnancy: up to 5-6 mg/day in the 2nd-3rd trimesters (fetal loading + expanded red cell mass)
Because excretion cannot be regulated, absorption is the sole control point for iron homeostasis.
11. Hereditary Hemochromatosis - When Regulation Fails
Mutations in HFE, TfR2, HJV (hemojuvelin), or hepcidin (HAMP) impair the iron-sensing signals that stimulate hepcidin, resulting in low circulating hepcidin and unchecked ferroportin activity:
In HH: mutated HFE/HJV/TfR2 cannot signal hepcidin synthesis; ferroportin runs unchecked → systemic iron accumulation at 0.5-1 g/year → disease manifests after ~20 g stored iron.
Iron accumulation causes organ damage via:
- Lipid peroxidation (iron-catalyzed Fenton reaction → ROS)
- Activation of hepatic stellate cells → collagen formation → cirrhosis
- DNA damage → hepatocellular carcinoma risk
- Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 788
12. Daily Iron Requirements Summary
| Group | Daily requirement |
|---|
| Adult male | ~13 µg/kg (~1 mg/day) |
| Menstruating female | ~21 µg/kg (~1.4 mg/day) |
| Pregnancy (2nd-3rd trimester) | ~80 µg/kg (~5-6 mg/day) |
| Infant | ~67 µg/kg |
- Goodman & Gilman's The Pharmacological Basis of Therapeutics, p. 928
Key take-home points:
- Iron is always protein-bound - free iron is toxic (Fenton chemistry)
- The body conserves iron tightly; 80-90% of daily needs come from macrophage recycling of old RBCs
- Hepcidin-ferroportin is the master regulatory axis at the systemic level
- IRP-IRE system handles cell-level iron sensing
- Absorption is the only adjustable output - there is no regulated excretion
- DMT1 (apical uptake) and ferroportin (basolateral export) are the critical transport proteins in the intestinal enterocyte